China’s Qilu Pharmaceutical has distributed all of the chemotherapy cisplatin that was imported as a result of the shortage ...
The FDA subsequently allowed imports of the cancer drug from China, from Qilu Pharmaceutical, whose version of the drug is unapproved in the U.S. Georgia’s elected officials are asking the FDA ...
A ROUND THE world, dealmaking is in a rut. A combination of higher interest rates, geopolitical tensions and economic uncertainty has put a hold on joint ventures, mergers and acquisitions. One ...
The Cancer Drugs Market is estimated to be valued at US$ 143.9 Bn in 2022 and is expected to exhibit a CAGR of 7.60% over the ...
More than 200 drugs are now facing a critical nationwide shortage, including penicillin and amoxicillin, two widely used ...
An Israeli company that has a U.S. headquarters in Waltham said Monday it has received approval for a new drug for blood cancer. Biopharmaceutical company BioLineRx Ltd. (Nasdaq: BLRX) said the U ...
An Israeli company developing treatments for cancers and rare disease said Monday it has received approval for a new drug after completing clinical trials in partnership with Washington University.
Merck & Co Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Wednesday the U.S. Food and Drug Administration (FDA) ...
HT-KIT received Orphan Drug Designation from FDA for its mRNA Frame Shifting Cancer Therapeutic Hoth intends to initially target mast cell neoplasms for development of HT-KIT, which is a rare ...
FDA reduced the therapeutic equivalence rating for Accord Healthcare's tacrolimus oral capsules due to safety concerns. The generic is still approved and allowed to be prescribed.
A Food and Drug Administration advisory panel on Tuesday unanimously concluded that oral phenylephrine, the decongestant found in many common cold medications, is ineffective. Phenylephrine is ...
The FDA subsequently allowed imports of the cancer drug from China, from Qilu Pharmaceutical, whose version of the drug is unapproved in the U.S. Georgia’s elected officials are asking the FDA ...
